ClearBridge Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

ClearBridge Investments’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,801,486	Closed	-$205M	–	1226
2017 Q4	$205M	Sell	3,801,486 -31,236	-0.8%	-$1.71M	0.19%	134
2017 Q3	$219M	Sell	3,832,722 -36,551	-0.9%	-$2.14M	0.21%	129
2017 Q2	$233M	Sell	3,869,273 -13,406	-0.3%	-$763K	0.23%	122
2017 Q1	$211M	Buy	+3,882,679	New	+$191M	0.21%	127

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

ClearBridge Investments's BIVV Position: Q1 2018 in Review

ClearBridge Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,801,486 shares — an estimated $205M sold.

ClearBridge Investments first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $233M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

ClearBridge Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
ClearBridge Investments sold 3,801,486 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $205M.
ClearBridge Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
ClearBridge Investments's Bioverativ Inc. Common Stock position peaked at $233M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on ClearBridge Investments's 13F filing for Q1 2018, filed 15 May 2018.